Business
InMode to Report First Quarter 2020 Financial Results on May 6, 2020
- Conference Call to be held that day at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 7, 2020 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global
About this update from Inmode Ltd.
[{"type":"text","content":"- Conference Call to be held that day at 8:30 a.m. Eastern Time\n\n\nYOKNEAM, Israel, April 7, 2020 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its results for the first quarter 2020 before the Nasdaq market opens on Wednesday, May 6, 2020. \nMr. Moshe Mizrahy, Chairman and Chief Executive Officer, and Mr. Yair Malca, Chief Financial Officer, will host a conference call that same day, May 6, 2020, at 8:30 a.m. Eastern Time. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your call five minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number. \nU.S. Toll-Free Dial-in Number: 1-866-777-2509 Israel Toll- Free Dial-in Number: 1-80-921-2373 International Dial-in Number: 1-412-317-5413 At: 8:30 a.m. Eastern Time 5:30 a.m. Pacific Time 3:30 p.m. Israel Time \nThe conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/. A replay of the conference call will be available from May 6, 2020 at 11:30 a.m. Eastern Time to May 20, 2020 at 11:29 a.m. Eastern Time. To access the replay, please dial one of the following numbers: Replay Dial-in U.S TOLL-FREE: 1-877-344-7529 \nReplay Dial-in Canada TOLL-FREE: 855-669-9658 Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088 Replay Pin Number: 10141879 \nA replay will also be available for 90 days on InMode's website at https://inmodemd.com/investors/ \nAbout InMode \nInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency (\"RF\") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. \nFor more information about InMode, please visit www.inmodemd.com. \nForward-Looking Statements \nThis press release contains certain forward-looking statements. Words such as \"expects\" and \"strives\" or similar expressions are inten...